Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,442 | 4 | 92.3% |
| Food and Beverage | $203.40 | 6 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $1,528 | 2 | $0 (2019) |
| Alkermes, Inc. | $976.16 | 5 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $111.60 | 1 | $0 (2023) |
| Allergan Inc. | $15.51 | 1 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $14.54 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,075 | 5 | Alkermes, Inc. ($963.83) |
| 2019 | $1,558 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($1,528) |
| 2018 | $12.33 | 1 | Alkermes, Inc. ($12.33) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2023 | Alkermes, Inc. | — | Travel and Lodging | In-kind items and services | $557.80 | General |
| 11/20/2023 | Alkermes, Inc. | — | Travel and Lodging | In-kind items and services | $309.74 | General |
| 11/20/2023 | Alkermes, Inc. | — | Travel and Lodging | In-kind items and services | $86.61 | General |
| 11/20/2023 | Alkermes, Inc. | — | Food and Beverage | In-kind items and services | $9.68 | General |
| 04/22/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $111.60 | General |
| 11/13/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | Cash or cash equivalent | $1,487.80 | General |
| 03/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | Cash or cash equivalent | $39.74 | General |
| 10/17/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: CNS | ||||||
About Dr. Wayne Macfadden, MD
Dr. Wayne Macfadden, MD is a Psychiatry healthcare provider based in Haddonfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1558500199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Macfadden, MD has received a total of $2,645 in payments from pharmaceutical and medical device companies, with $1,075 received in 2023. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($2,442).
Practice Information
- Specialty Psychiatry
- Location Haddonfield, NJ
- Active Since 02/04/2009
- Last Updated 02/04/2009
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558500199
Products in Payments
- VRAYLAR (Drug) $15.51
- INGREZZA (Drug) $14.54
- Vivitrol 380 mg (Drug) $12.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Haddonfield
Dr. Nalini Naik, M.d, M.D
Psychiatry — Payments: $2,893
Dr. Jamie Mullen, M.d, M.D
Psychiatry — Payments: $1,330
Dr. Nicole Post, M.d, M.D
Psychiatry — Payments: $1,240
Dr. Walden Holl, M.d, M.D
Psychiatry
Dr. Patrick Stumpo, D.o, D.O
Psychiatry
Dr. Emily Liberatore-Maguire, Md, MD
Psychiatry